Franklin Street Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Franklin Street Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-56,330	Closed	-$422K	–	167
2021 Q4	$422K	Buy	56,330 +2,500	+5%	+$21.7K	0.03%	118
2021 Q3	$485K	Sell	53,830 -880	-2%	-$8.7K	0.04%	111
2021 Q2	$655K	Buy	54,710 +44,000	+411%	+$498K	0.06%	96
2021 Q1	$134K	Sell	10,710 -2,070	-16%	-$27.9K	0.01%	148
2020 Q4	$199K	Hold	12,780	–	–	0.02%	144
2020 Q3	$121K	Sell	12,780 -25,000	-66%	-$270K	0.01%	135
2020 Q2	$339K	Hold	37,780	–	–	0.04%	113
2020 Q1	$241K	Buy	37,780 +25,000	+196%	+$186K	0.04%	118
2019 Q4	$107K	Hold	12,780	–	–	0.01%	150
2019 Q3	$116K	Hold	12,780	–	–	0.01%	151
2019 Q2	$138K	Buy	12,780 +880	+7%	+$9.36K	0.02%	153
2019 Q1	$114K	Hold	11,900	–	–	0.02%	149
2018 Q4	$137K	Sell	11,900 -29,000	-71%	-$360K	0.02%	139
2018 Q3	$693K	Sell	40,900 -500	-1%	-$7.6K	0.09%	88
2018 Q2	$588K	Buy	41,400 +1,000	+2%	+$16.6K	0.09%	92
2018 Q1	$768K	Sell	40,400 -5,800	-13%	-$124K	0.12%	87
2017 Q4	$758K	Sell	46,200 -10,300	-18%	-$153K	0.11%	92
2017 Q3	$848K	Hold	56,500	–	–	0.14%	87
2017 Q2	$497K	Sell	56,500 -20,000	-26%	-$128K	0.09%	99
2017 Q1	$398K	Buy	+76,500	New	+$307K	0.07%	118
2016 Q4	–	Sell	-11,000	Closed	-$51K	–	178
2016 Q3	$51K	Sell	11,000 -42,500	-79%	-$216K	0.01%	177
2016 Q2	$310K	Hold	53,500	–	–	0.06%	156
2016 Q1	$324K	Hold	53,500	–	–	0.06%	171
2015 Q4	$489K	Sell	53,500 -2,500	-4%	-$19.3K	0.1%	142
2015 Q3	$316K	Hold	56,000	–	–	0.06%	175
2015 Q2	$621K	Hold	56,000	–	–	0.11%	137
2015 Q1	$878K	Sell	56,000 -30,000	-35%	-$464K	0.16%	117
2014 Q4	$1.31M	Hold	86,000	–	–	0.25%	97
2014 Q3	$928K	Sell	86,000 -18,750	-18%	-$245K	0.18%	115
2014 Q2	$1.6M	Sell	104,750 -40,900	-28%	-$588K	0.31%	77
2014 Q1	$2.63M	Buy	145,650 +650	+0.4%	+$12.5K	0.53%	55
2013 Q4	$2.01M	Sell	145,000 -4,800	-3%	-$55.3K	0.41%	72
2013 Q3	$1.57M	Buy	149,800 +28,000	+23%	+$278K	0.35%	78
2013 Q2	$951K	Buy	+121,800	New	+$1.06M	0.23%	116

Other funds holding SGMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Street Advisors's SGMO Position: Q1 2022 in Review

Franklin Street Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2022, closing a stake of 56,330 shares — an estimated $422K sold.

Franklin Street Advisors first reported a position in SGMO in Q2 2013 and held it in 34 quarters. The position peaked at $2.63M in Q1 2014. 195 funds tracked by Wall St. Rank hold SGMO as of Q1 2022.

Franklin Street Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2022 after selling out during the quarter.
Franklin Street Advisors sold 56,330 SANGAMO THERAPEUTICS INC shares in Q1 2022, an estimated $422K.
Franklin Street Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 34 quarters.
Franklin Street Advisors's SANGAMO THERAPEUTICS INC position peaked at $2.63M in Q1 2014.
195 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2022.

Based on Franklin Street Advisors's 13F filing for Q1 2022, filed 18 Apr 2022.